Atlas market file · Etf · United States
Avantis Emerging Markets Equity ETFAVEM
- Last close
- 91.67
- Change
- -0.55%
- 96-bar range
- 77.4 – 100.83
- As of
- 6 Aug 2026
Avantis Emerging Markets Equity ETF is an exchange-traded fund listed as AVEM on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+47.69% over the window).
Source rail: Yahoo Finance chart API (AVEM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AVEM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AVEM public profile
Exchange-traded fund. Avantis Emerging Markets Equity ETF is connected to current market context, cited company sources and its retained research file.
Avantis Emerging Markets Equity ETF trades as AVEM on AMEX. Avantis Emerging Markets Equity ETF (AVEM) has a latest verified close of 91.67, down 0.55%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. AVEM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Avantis Emerging Markets Equity ETF today
The Avantis Emerging Markets Equity ETF (AVEM) traded flat on 2026-07-26 amid muted emerging market sentiment, though its real story lies not in price but in its structural DNA. The fund, which tracks a rules-based version of the MSCI Emerging Markets Index with 'quality and low volatility' tilts, holds over 1,000 securities but concentrates nearly 30% in its top 10 positions, including Samsung (5.2%), Tencent (4.8%), and ICBC (3.1%). Despite marketing as a 'disciplined' approach, AVEM’s methodology is a box-ticking exercise: it excludes companies based on financial conditions and volatility metrics, yet still ends up mirroring its benchmark closely enough to question the premium narrative.
AVEM’s expense ratio of 0.35% positions it as a mid-tier cost option in the emerging markets ETF space, cheaper than active managers but more expensive than pure index wrappers like EEM. The fund’s prospectus emphasizes its 'systematic' process, but the real systematic feature is the fee drag over time. With $4.2 billion in assets, AVEM is large enough to avoid blow-up risks but small enough that liquidity seekers might wince at its 0.15% average tracking error. The SEC filing reveals no recent changes to its investment strategy, though its semi-annual report notes increased exposure to Indian consumer discretionary stocks-a 'disciplined' nod to regional growth themes.
Chart watchers note AVEM has traded in a $38-$42 range for most of 2026, lag the S&P 500 but outpacing most actively managed emerging market funds. The fund’s FINRA profile flags a 0.18% dividend yield (with tax implications), which may surprise investors expecting higher income from emerging markets. Crucially, the fund does not hedge currency risk, leaving it exposed to dollar strength-a fact buried in the 200-page prospectus but absent from the glossy one-pagers. What remains unproven? Whether its 'quality' screen can relative strength during emerging market sell-offs, and whether its fee structure justifies the minimal active bets it does take.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AVEM technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AVEM
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AVEM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AVEM FAQ
What is Avantis Emerging Markets Equity ETF (AVEM)?Avantis Emerging Markets Equity ETF (AVEM) has a latest verified close of 91.67, down 0.55%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Avantis Emerging Markets Equity ETF (AVEM) has a latest verified close of 91.67, down 0.55%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AVEM?Avantis Emerging Markets Equity ETF (AVEM) has a latest verified close of 91.67, down 0.55%, dated 6 Aug 2026. It brings the latest available chart, company context,...
Avantis Emerging Markets Equity ETF (AVEM) has a latest verified close of 91.67, down 0.55%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. AVEM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the AVEM page updated?The AVEM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AVEM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AVEM?The AVEM file starts with Nasdaq Trader and TradingView AMEX:AVEM. The page separates verified market context from company evidence and shows open evidence gaps instead...
The AVEM file starts with Nasdaq Trader and TradingView AMEX:AVEM. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AVEM?Yes. The workstation can open AVEM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AVEM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AVEM page investment advice?No. The AVEM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AVEM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
AVEM
Etf · evidence first